Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary
- PMID: 8090722
- PMCID: PMC44689
- DOI: 10.1073/pnas.91.19.8777
Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary
Abstract
Corticotropin-releasing factor (CRF) is a major hypophysiotropic peptide regulating pituitary-adrenal response to stress, and it is also widely expressed in the central nervous system. The recent cloning of cDNAs encoding the human and rat CRF receptors has enabled us to map the distribution of cells expressing CRF receptor mRNA in rat brain and pituitary by in situ hybridization. Receptor expression in the forebrain is dominated by widespread signal throughout all areas of the neo-, olfactory, and hippocampal cortices. Other prominent sites of CRF receptor mRNA expression include subcortical limbic structures in the septal region and amygdala. In the diencephalon, low levels of expression are seen in a few discrete ventral thalamic and medial hypothalamic nuclei. CRF receptor expression in hypothalamic neurosecretory structures, including the paraventricular nucleus and median eminence, is generally low. In the brainstem, certain relay nuclei associated with the somatic (including trigeminal), auditory, vestibular, and visceral sensory systems, constituted prominent sites of CRF receptor mRNA expression. In addition, high levels of this transcript are present in the cerebellar cortex and deep nuclei, along with many precerebellar nuclei. In the pituitary, moderate levels of CRF receptor mRNA expression were detected throughout the intermediate lobe and in a subset of cells in the anterior lobe identified as corticotropes by concurrent immunolabeling. Overall, the central distribution of CRF receptor mRNA expression is similar to, though more expansive than, that of regions reported to bind CRF, and it shows limited overlap with loci expressing CRF-binding protein. Interestingly, CRF receptor mRNA is low or undetectable in several cell groups implicated as central sites of CRF action.
Similar articles
-
The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF.Proc Natl Acad Sci U S A. 1992 May 1;89(9):4192-6. doi: 10.1073/pnas.89.9.4192. Proc Natl Acad Sci U S A. 1992. PMID: 1315056 Free PMC article.
-
Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse.J Comp Neurol. 2000 Dec 11;428(2):191-212. doi: 10.1002/1096-9861(20001211)428:2<191::aid-cne1>3.0.co;2-u. J Comp Neurol. 2000. PMID: 11064361
-
Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression.J Neurosci. 1995 Oct;15(10):6340-50. doi: 10.1523/JNEUROSCI.15-10-06340.1995. J Neurosci. 1995. PMID: 7472399 Free PMC article.
-
Receptor-mediated actions of corticotropin-releasing factor in pituitary gland and nervous system.Neuroendocrinology. 1986;43(1):79-88. doi: 10.1159/000124513. Neuroendocrinology. 1986. PMID: 3012395 Review.
-
Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides.Front Neuroendocrinol. 1995 Oct;16(4):362-82. doi: 10.1006/frne.1995.1013. Front Neuroendocrinol. 1995. PMID: 8557170 Review.
Cited by
-
Regulation of gonadotropins by corticotropin-releasing factor and urocortin.Front Endocrinol (Lausanne). 2013 Feb 20;4:12. doi: 10.3389/fendo.2013.00012. eCollection 2013. Front Endocrinol (Lausanne). 2013. PMID: 23431022 Free PMC article.
-
Cognitive disruptions in stress-related psychiatric disorders: A role for corticotropin releasing factor (CRF).Horm Behav. 2015 Nov;76:125-35. doi: 10.1016/j.yhbeh.2015.04.003. Epub 2015 Apr 14. Horm Behav. 2015. PMID: 25888454 Free PMC article. Review.
-
Immunocytochemical distribution of corticotropin-releasing hormone receptor type-1 (CRF(1))-like immunoreactivity in the mouse brain: light microscopy analysis using an antibody directed against the C-terminus.J Comp Neurol. 2000 May 8;420(3):305-23. doi: 10.1002/(sici)1096-9861(20000508)420:3<305::aid-cne3>3.0.co;2-8. J Comp Neurol. 2000. PMID: 10754504 Free PMC article.
-
(3α,5α)3-Hydroxypregnan-20-one (3α,5α-THP) Regulation of the HPA Axis in the Context of Different Stressors and Sex.Biomolecules. 2022 Aug 18;12(8):1134. doi: 10.3390/biom12081134. Biomolecules. 2022. PMID: 36009028 Free PMC article.
-
Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses.Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13;33(8):1291-308. doi: 10.1016/j.pnpbp.2009.06.022. Epub 2009 Jul 10. Prog Neuropsychopharmacol Biol Psychiatry. 2009. PMID: 19595731 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
